Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1

Journal article

Open access

Peer reviewed

Andrew B Das, Purvi M Kakadia, Damian Wojcik, Lucy Pemberton, Peter J Browett, Stefan K Bohlander and Margreet C M Vissers

Blood cancer journal (New York), Vol.9(10), pp.82-5

02/10/2019

Handle:

https://hdl.handle.net/10523/36788

Abstract

Antioxidants - therapeutic use

Ascorbic Acid - therapeutic use

DNA-Binding Proteins - genetics

Humans

Leukemia, Myeloid, Acute - drug therapy

Leukemia, Myeloid, Acute - genetics

Proto-Oncogene Proteins - genetics

Remission Induction

Treatment Outcome

WT1 Proteins - genetics

Centre for Redox Biology & Medicine Collection

url

https://doi.org/10.1038/s41408-019-0242-4View

Published (Version of record) Open

6 Record Views

Record Identifier: 9926529322901891
Title: Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
Creators: Andrew B Das
Purvi M Kakadia
Damian Wojcik
Lucy Pemberton
Peter J Browett
Stefan K Bohlander
Margreet C M Vissers
Publication Details: Blood cancer journal (New York), Vol.9(10), pp.82-5
Academic Unit: Pathology and Molecular Medicine (UOC)
Date published ; e-published: 02/10/2019
Language: English
Resource Type ; Subtype: Journal article